| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
8e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
| mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |